No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.
Patient activation, earned trust and health literacy at patient, provider and health system levels are critical to overcoming ...
To present the pioneering concept, Peer and his team encoded the anti-inflammatory protein interleukin-10 into mRNA and ...
GlobalData on MSN3d
FDA fast tracks Bracco’s BR55 for Crohn’s disease bowel inflammation detectionEngineered to specifically act on the vascular endothelial growth factor receptor 2 (VEGFR2), BR55 (perfluorobutane/nitrogen lipopeptide-coated microbubbles) injection claims to i ...
The findings from the PROSPERO study reveal that multiple hospitalizations, long-term disease duration, prior surgeries, and factors like corticosteroid use and total parenteral nutrition ...
Crohn’s disease isn’t just about digestion. From joint pain to vision issues, its hidden symptoms affect the body in unexpected ways.
Inflammatory bowel diseases (IBDs), which include ulcerative colitis (UC) and Crohn’s disease (CD), are chronic conditions ...
Since the first, seminal randomised controlled trial (RCT) in inflammatory bowel disease (IBD) in 1955,1 the central tenets for high-quality clinical trials have been recognised as robust and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback